Abstract
Advances in strategies for treating a wide variety of diseases require an efficient delivery of the active compounds into the cytosol of target cells. One of the challenges for the efficient intracellular delivery of therapeutic biomolecules after their cell internalization by endocytosis is to manipulate or circumvent the non-productive trafficking from endosomes to lysosomes, where degradation may occur. Because the nanocarriers generally cannot directly cross the lipid bilayer of the endosomes, the pH targeting approach, which can lead to as elective disruption of the endosomal membrane, is regarded as a promising strategy to promote a specific triggered release of active biomolecules. The combination of the endosomal acidity with the endosomolytic capability of the nanocarrier can increase the intracellular delivery of many drugs, genes and proteins, which, therefore, might enhance their therapeutic efficacy and, in specific cases, overcome the multidrug resistance of many bacterial and tumor cells. Different approaches have been taken to develop pHsensitive drug delivery devices, including the incorporation of pH-responsive polymers, peptides, surfactants and fusogenic lipids. This review focuses on the recent progress in pH-sensitive nanocarriers and their performance as nanoscale strategies for the intracellular drug, gene and protein delivery, with emphasis on their specificity to the acidic environment of the endosomal compartments.
Keywords: Acidic environment, cell internalization, intracellular delivery, nanocarriers, nanotechnology, pH-sensitivity.
Drug Delivery Letters
Title:Nanotechnology Approaches to Target Endosomal pH: A Promising Strategy for an Efficient Intracellular Drug, Gene and Protein Delivery
Volume: 4 Issue: 1
Author(s): Daniele R. Nogueira, Montserrat Mitjans and Maria P. Vinardell
Affiliation:
Keywords: Acidic environment, cell internalization, intracellular delivery, nanocarriers, nanotechnology, pH-sensitivity.
Abstract: Advances in strategies for treating a wide variety of diseases require an efficient delivery of the active compounds into the cytosol of target cells. One of the challenges for the efficient intracellular delivery of therapeutic biomolecules after their cell internalization by endocytosis is to manipulate or circumvent the non-productive trafficking from endosomes to lysosomes, where degradation may occur. Because the nanocarriers generally cannot directly cross the lipid bilayer of the endosomes, the pH targeting approach, which can lead to as elective disruption of the endosomal membrane, is regarded as a promising strategy to promote a specific triggered release of active biomolecules. The combination of the endosomal acidity with the endosomolytic capability of the nanocarrier can increase the intracellular delivery of many drugs, genes and proteins, which, therefore, might enhance their therapeutic efficacy and, in specific cases, overcome the multidrug resistance of many bacterial and tumor cells. Different approaches have been taken to develop pHsensitive drug delivery devices, including the incorporation of pH-responsive polymers, peptides, surfactants and fusogenic lipids. This review focuses on the recent progress in pH-sensitive nanocarriers and their performance as nanoscale strategies for the intracellular drug, gene and protein delivery, with emphasis on their specificity to the acidic environment of the endosomal compartments.
Export Options
About this article
Cite this article as:
R. Nogueira Daniele, Mitjans Montserrat and P. Vinardell Maria, Nanotechnology Approaches to Target Endosomal pH: A Promising Strategy for an Efficient Intracellular Drug, Gene and Protein Delivery, Drug Delivery Letters 2014; 4 (1) . https://dx.doi.org/10.2174/221030310401140410115042
DOI https://dx.doi.org/10.2174/221030310401140410115042 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Innovative Drug Delivery Systems in Dentistry: Bridging Technology and Clinical Practice
This study explores the integration of advanced drug delivery technologies in dental practice, aiming to enhance therapeutic outcomes, patient compliance, and precision in treatment. It encompasses a wide range of systems, including nanoparticles, hydrogels, bioresorbable scaffolds, microneedles, mucoadhesive patches, and sustained-release implants tailored for oral and periodontal applications. The scope ...read more
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Avenue of Research: Antiepileptic Drug and Estradiol Neuroprotection in Epilepsy
Recent Patents on CNS Drug Discovery (Discontinued) Neurorestorative Effect of Urinary Bladder Matrix-Mediated Neural Stem Cell Transplantation Following Traumatic Brain Injury in Rats
CNS & Neurological Disorders - Drug Targets Vascular Effects of Ambient Pollutant Particles and Metals
Current Vascular Pharmacology β-Sheet Breakers for Alzheimers Disease Therapy
Current Drug Targets Epigenetic Changes in the Methylation Patterns of KCNQ1 and WT1 after a Weight Loss Intervention Program in Obese Stroke Patients
Current Neurovascular Research Treatment of Mild Cognitive Impairment (MCI)
Current Alzheimer Research Recent Patents on Drugs Addressing Neurodegenerative Diseases
Recent Patents on Biomarkers Humanin: A Possible Linkage Between Alzheimer’s Disease and Type 2 Diabetes
CNS & Neurological Disorders - Drug Targets Current and Future Therapeutic Strategies to Target Inflammation in Stroke
Current Drug Targets - Inflammation & Allergy Antithrombotic Therapy in Cardiac Embolism
Current Cardiology Reviews A Review on the Role of Phytosterols: New Insights Into Cardiovascular Risk
Current Pharmaceutical Design Caregiver Burden in Fragile X Families
Current Psychiatry Reviews Generation of Alzheimer’s Disease Transgenic Zebrafish Expressing Human APP Mutation Under Control of Zebrafish appb Promotor
Current Alzheimer Research Clinical Significance of the Cardio-Ankle Vascular Index (CAVI) in Hypertension
Current Hypertension Reviews Fibrinogen: A Predictor of Vascular Disease
Current Pharmaceutical Design Stroke History is an Independent Risk Factor for Poor Prognosis in Ischemic Stroke Patients: Results from a Large Nationwide Stroke Registry
Current Neurovascular Research The Role of β-Amyloid Protein in Synaptic Function: Implications for Alzheimers Disease Therapy
Current Neuropharmacology Nanowired Drug Delivery of Antioxidant Compound H-290/51 Enhances Neuroprotection in Hyperthermia-Induced Neurotoxicity
CNS & Neurological Disorders - Drug Targets A Therapeutic Target of Cerebral Hemorrhagic Stroke: Matrix Metalloproteinase- 9
Current Drug Targets SUBJECT INDEX
Current Neuropharmacology